Created by Khin Soe.
Platelets (small plates), also known as thrombocytes, (thrombo = clot; cytes = cells) have following features:
Platelets are the smallest blood cells varying in diameter from 2 to 4 μm with an average volume of 5.8 μm3.
Platelets are colourless, spherical or oval discoid structures.
Leishman staining shows a platelet consisting of faint bluish cytoplasm containing reddish purple granules.
Nucleus is absent in the platelets and therefore these cannot be reproduced.
Under electron microscope a platelet shows following structural and compositional characteristics
Glycoproteins forming the surface coat of the platelet membrane prevent adherence of platelets to normal endothelium
but accelerate the adherence of platelets to collagen and damaged endothelium in injured blood vessels.
Phospholipids of the platelet membrane contain platelet factor-3, which plays an activating role at several points in the blood clotting process.
Invagination of the surface membrane forms the socalled canalicular system or the surface connecting system.
Receptors present on the platelet membrane are meant for combining with specific substances like collagen and fibrinogen.
Precursors of various substances like thromboxane A2, prostaglandins, leukotrienes and platelet factors 3 and 4 are also present.
These form a compact bundle present immediately beneath the platelet membrane, responsible for maintenance of discoid shape of the circulating platelets.
Proteins and Granules: Fibrin stabilizing factor, – Platelet-derived growth factor (PDGF) and – Von Willebrand factor, - serotonin (5HT), - Clotting factors and PDGF.
Adhesiveness: when they come in contact with any wet surface or rough surface, they get activated and stick to the surface.
Factors responsible for adhesiveness are collagen, thrombin, ADP, thromboxane A2, calcium ions and von Willebrand factor.
Platelets have the property to aggregate, i.e. they stick to each other. This is due to ADP and thromboxane A2.
Clumping together of platelets is called agglutination. This occurs due to the actions of some platelet agglutinins.
Role in haemostasis. Haemostasis refers to the spontaneous arrest of bleeding from an injured blood vessel. Platelets play roles in haemostasis.
Contraction of contractile proteins (actin, myosin and thrombosthenin) present in the platelets play an important role in clot retraction.
Normal platelet count ranges from 150,000 to 450,000/mm3, with an average count of 2.5 lakh/mm3.
Thrombocytosis. An increase in the number of platelets more than 4.5 lakh/mm3 is called thrombocytosis.
Decrease in the number of platelets below 1.5 lakh/mm3 is called thrombocytopenia.
Idiopathic thrombocytopenic purpura
Acute leukaemia or secondary deposits of malignancy in the bone marrow
Thrombopoiesis seems to be regulated by following humoral factors: Thrombopoietin and Megakaryocyte colony stimulating activity (Meg-CSA).
Life span of platelets varies from 8 to 12 days with an average of 10 days. Platelets are destroyed by tissue macrophage system in spleen.
Haemostasis refers to the spontaneous arrest or prevention of bleeding from the injured/damaged vessels by the physiological process.
Initial vasoconstriction is caused by direct effect of injury on the vascular smooth muscles. The initial vasoconstriction is transient but
Enterochromaffine cells (EC-cells) in the gut express Tph1 and synthesize the majority of peripheral serotonin (5-HT). EC-cells release 5-HT into the blood plasma, where it is taken up by platelets.
Platelets, as the main circulating reservoir, store 5-HT in their dense granules.
Platelets, as the main circulating reservoir, store 5-HT in their dense granules.
is maintained for several minutes or even hours by humoral facilitation due to release of 5HT and other vasoconstrictors.
Platelet adhesion. Following injury platelets become sticky and therefore adhere to the collagen of damaged cell wall and to the damaged endothelium.
Platelets activation. The platelets secrete large quantities of ADP and thromboxane A2, which act on the nearby platelets and cause their activation.
Platelets aggregation. The large numbers of activated sticky platelets stick to each other forming platelets aggregation.
The temporary platelet plug is converted into the definitive haemostatic plug by the process of clot formation (blood coagulation).
Platelets play an important role in the formation of the intrinsic prothrombin activator which is responsible for initiating the process of clot formation.
When the blood is shed from the blood vessels or collected in a container, it looses its fluidity within a few minutes and
gets converted into a jelly-like mass called clot. This phenomenon is called coagulation or clotting of blood.
Within a few minutes after a clot is formed, it begins to contract and usually squeeze out most of the fluid called serum (plasma without fibrinogen and other clotting factors) within 30–60 min.
The contractile proteins (platelet thrombosthenin, actin and myosin) present in the cytoplasm of platelets cause strong contraction of platelet spicules attached to fibrin fibres.
In the liver, synthesis of following factors is dependent upon vitamin K: Coagulant like prothrombin, Factors VII, IX and X, and Circulatory anticoagulant protein.
1. Velocity of circulation. Blood is pumped into the vessels and circulated at a constant velocity, which contributes to its fluidity.
Smoothness of the endothelial lining inhibits platelet adhesion.
A layer of glycocalyx (mucopolysaccharide) adsorbed to the inner surface of endothelium being negatively charged repels clotting factors (anion proteins) and platelets, and thereby prevents clotting.
Intact endothelium acts as a barrier between the thrombogenic subendothelial collagenous tissue and the blood.
Intact endothelium acts as a barrier between the thrombogenic subendothelial collagenous tissue and the blood.
Circulatory anticoagulants or the so-called natural anticoagulants present in the blood which prevent clotting are: Heparin, Antithrombin III, α2 macroglobulin and Protein C.
Protein C is a naturally occurring anticoagulant which inactivates factors V and VIII and also inactivates an inhibitor of tissue plasminogen activator.
Liver plays a role in preventing the intravascular clotting by removing activated clotting factors in the event of onset of spontaneous clot formation.
Under certain pathological conditions the intravascular clotting may occur. The intravascular clotting is called thrombosis and the clot so formed is called thrombus.
1. Ischaemia and infarction.
Pulmonary embolism and Cerebral embolism.